ArticleNPJ precision oncology2024

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.

Anjali Geethadevi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.